Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
JAMA Network Open|June 26, 2026
Economic and Resource Use-Related Guidance in US Medical Societies' Clinical Practice GuidelinesAnand R Habib, Omar Qureshi, Reshma Ramachandran, et al.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|February 5, 2014
Correlation of hyponatremia with hepatic encephalopathy and severity of liver diseaseMuhammad Omar Qureshi, Nasir Khokhar, Atif Saleem, et al.Journal of Immunological Methods|December 21, 2017
A simple method for measuring immune complex-mediated, Fc gamma receptor dependent antigen-specific activation of primary human T cellsFabian Junker, Sinduya Krishnarajah, Omar Qureshi, et al.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|September 20, 2014
Renal failure in patients with end stage liver disease and its impact on clinical outcomeMuhammad Omar Qureshi, Farzana Shafqat, Faisal Saud Dar, et al.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|October 31, 2013
Factors affecting patient satisfaction during endoscopic proceduresMuhammad Omar Qureshi, Farzana Shafqat, Shafiq Ahmed, et al.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|July 26, 2015
Quality of Colonoscopy and Spectrum of Lower Gastrointestinal Disease as Determined by ColonoscopyKhalil Ur Rehman, Muhammad Omar Qureshi, Nasir Khokhar, et al.Stroke (Hoboken, N.J.)|January 29, 2026
Applying a Random Forest Approach in Predicting Health Status in Patients with Carotid Artery Stenosis 30 Days Post StentingOmar Qureshi, Carlos Mena-Hurtado, Gaëlle Romain, et al.Nephron|May 4, 2019
Spontaneous Extracellular Matrix Accumulation in a Human in vitro Model of Renal Fibrosis Is Mediated by αV IntegrinsHélène Bon, Paul Hales, Simon Lumb, et al.Journal of Gastroenterology and Hepatology|April 14, 2015
Comparison of once a day rifaximin to twice a day dosage in the prevention of recurrence of hepatic encephalopathy in patients with chronic liver diseaseNasir Khokhar, Muhammad Omar Qureshi, Shafiq Ahmad, et al.Plos One|December 21, 2021
Fc-engineered antibodies with immune effector functions completely abolishedIan Wilkinson, Stephen Anderson, Jeremy Fry, et al.Pageof 4